Page-3 of Current Affairs - November, 2012
ECB window to widen
ECB: External Commercial Borrowing The government is all set to widen the scope of ECB. This will be done via including sectors incorporated in the new definition of infrastructure, approved by the Cabinet committee on infrastructure. Objective: This will permit ..
Month: Current Affairs - November, 2012
India’s plans to modify ITRs opposed by Civil society and industry
International Telecommunications Regulations (ITRs) India’s made a proposal on ITRs and submitted the same to the International Telecommunications Union (ITU) in October, 2012. The proposal has drawn opposition from, and fears of content control among, civil society and the industry. ..
Month: Current Affairs - November, 2012
Category: International / World Current Affairs
Liquid Index ETFs shall be eligible for trading in the SLB segment: SEBI
As part of changes in the securities lending and borrowing framework, SEBI has permitted ETFs (Exchange Traded Funds) that track indices to trade in the short selling market. Liquid Index ETFs shall be eligible for trading in the Securities Lending ..
Month: Current Affairs - November, 2012
Category: Reports & Indexes Current Affairs
India successfully test fired supersonic interceptor missile
Giving a boost to Ballistic Missile Defence (BMD) capability, India successfully launched an interceptor missile to destroy an incoming target missile in a accurate hit at an altitude of 15 km over the Bay of Bengal. The target missile played ..
Month: Current Affairs - November, 2012
Security OF D8 leaders a major concern for Pakistan
For Pakistan, who is hosting D8 summit, security of the group’s leaders has become a major challenge amid increasing incidents of suicide attacks. What is D8? D8 or Developing 8 is the group of 8 developing nations with large Muslim ..
Month: Current Affairs - November, 2012
Category: International / World Current Affairs
Aurobindo Pharma recalled anti-depressant drug from US
Hyderabad based Aurobindo Pharma Ltd recalled Mirtazapine drug from the US market due to the product not meeting a specification for a known degradation product during routine stability testing. The drug is an anti-depressant and generally indicated for treatment of ..